Carmed Pharmaceuticals, a Turkey-based, science-driven company specializing in standardized carvacrol-based formulations, has earned editorial coverage in CityBiz through a featured executive Q&A with Founder Mustafa Can as the company continues expanding into the United States market.

The CityBiz interview explores Can’s unconventional journey from ship master in the maritime industry to founder of a research-focused pharmaceutical company built around standardized botanical formulations and long-term scientific development. The feature also discusses Carmed’s formulation philosophy, ongoing research initiatives, and strategy for entering the U.S. wellness market.

In the interview, Can explains how a personal interest in longevity and preventive wellness led him into years of independent research studying botanical compounds and formulation science before formally establishing Carmed Pharmaceuticals.

“Over time, this personal journey evolved into something more structured,” Can said in the CityBiz feature. “I became increasingly focused on how to develop standardized, reproducible formulations based on bioactive compounds like carvacrol.”

The article also highlights Carmed’s emphasis on what the company describes as “rational synergy” - combining multiple bioactive compounds within standardized formulations designed around consistency, reproducibility, and analytical validation.

The CityBiz placement comes as Carmed continues building awareness in the United States through a multi-channel distribution strategy that includes both curated wellness platforms and large-scale digital marketplaces.

Several Carmed formulations are now available on OneLavi.com, including:

• Vacrol® Kids Spray - A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.

• S-Mix® - A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule - A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule - A multi-component botanical formulation designed to support immune function and respiratory wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

The company also previously announced plans to expand availability through Amazon as part of its broader U.S. rollout strategy.

“We believe educational visibility and accessibility must develop together,” said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. “The CityBiz feature helps communicate the philosophy behind Carmed while platforms like OneLavi and Amazon help make our formulations more accessible to consumers in the United States.”

The CityBiz interview also discusses Carmed’s commitment to scientific collaboration and ongoing research. According to the feature, Carmed works alongside physicians, researchers, laboratories, and academic partners to support formulation development and scientific evaluation.

In January 2026, research involving Carmed formulations Vacrol® and S-Mix® was published in the peer-reviewed journal Plants, where the formulations were examined in preclinical laboratory and in ovo models as part of broader scientific investigation into carvacrol-based botanical formulations.

The company emphasizes that this research reflects scientific investigation into formulation science and botanical bioactivity and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

Carmed states that its U.S. strategy is focused on long-term brand development through scientific credibility, regulatory alignment, educational visibility, and expanded consumer accessibility.

“Our goal is to build a company that is known for consistency, credibility, and a long-term commitment to research-driven development,” Can said in the CityBiz feature.

The full CityBiz Q&A with Mustafa Can can be viewed here.

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This contant was orignally distributed by Newsworthy.ai. Blockchain Registration, Verification & Enhancement provided by NewsRamp™. The source URL for this press release is Carmed Pharmaceuticals Highlights CityBiz Feature as U.S. Expansion Accelerates.